Investigation Overview
January 25, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Eleven Biotherapeutics Inc (NASDAQ:EBIO) shares over potential securities laws violations by Eleven Biotherapeutics Inc and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purcha...
You must register (for free) or login to view the entire investigation.